Results 151 to 160 of about 12,022 (202)

Sunvozertinib: shining light on lung cancer's exon 20 fight. [PDF]

Transl Lung Cancer Res
Mitsudomi T.
europepmc   +1 more source

Comparison of Side Effects of Anti-epidermal Growth Factor Receptor (Anti-EGFR) Antibody Drugs During Initial Induction and Reinduction in Colorectal Cancer: A Case Series. [PDF]

Cureus
Hoshida T, Tanabe K, Tsubaki M, Nagai N, Nishida S.   +4 more
europepmc   +1 more source

Global trends and hotspots in research of paronychia: A bibliometric analysis. [PDF]

Medicine (Baltimore)
Zhou C, Yu G, Wang Q, Yang Z, Wang H, Zhao Y.   +5 more
europepmc   +1 more source

Dermatologic Adverse Events Following Afatinib in a Woman with Non-Small-Cell Lung Cancer: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Tsaqilah L, Putri AD, Avriyanti E.
europepmc   +1 more source

Giant acquired digital fibrokeratoma secondary to paronychia: A case report

Dong Xiao, Jie Xiang, Yue Ma, Ying Lan
openalex   +1 more source

Selumetinib for symptomatic, inoperable plexiform neurofibromas in pediatric patients with neurofibromatosis type 1: the first single-center real-world case series in Japan. [PDF]

Jpn J Clin Oncol
Nishida Y, Nonobe N, Kidokoro H, Kato T, Takeichi T, Ikuta K, Urakawa H, Sakai T, Koike H, Fujito T, Imagama S.   +10 more
europepmc   +1 more source

Estudio polínico de la tribu paronychieae pax. (caryophyllaceae) en la Península Ibérica [PDF]

, 1999
Fernández González, Inmaculada, Juan Rodríguez, Rocío, Ocaña Amante, María Eugenia, Pastor Díaz, Julio Enrique   +3 more
core  

Cervical spine infection arising from chronic paronychia: A case report and review of literature. [PDF]

World J Orthop
Zhang D, Gan LY, Zhang WJ, Shi M, Zhang L, Zhang Y, Liu MW.   +6 more
europepmc   +1 more source

FDA approval of mirdametinib for NF1-associated plexiform neurofibromas: clinical and regulatory perspectives. [PDF]

Ann Med Surg (Lond)
Sheikh M, Haider E, Irshad NUN, Imran SB.   +3 more
europepmc   +1 more source